Inside informationEnglish
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- DBV Technologies
- Filed
- 28/03/2025, 03:30
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 116670_20250328